Acute Suspected Stroke Clinical Pathway Use in Tasmanian Emergency Departments: A Retrospective Study
Abstract
Stroke is a leading cause of disability and healthcare burden in Australia, affecting over 440,000 people. Timely diagnosis and intervention are essential for improving outcomes, and national ED standards emphasise rapid assessment, imaging and treatment. Clinical pathways aim to standardise care and reduce delays, yet regional disparities persist. This study examined suspected acute stroke pathway use in Tasmanian EDs, assessing guideline adherence, waiting times and inter‐hospital variation.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.